Research progress of N6-methyladenosine modification in prostate cancer
10.3760/cma.j.cn115396-20210510-00171
- VernacularTitle:m6A修饰在前列腺癌中的研究进展
- Author:
Ye YUAN
1
;
Hao HUANG
;
Wei TAN
;
Zili HU
Author Information
1. 重庆医科大学附属第二医院泌尿外科 400010
- Keywords:
Methylation;
6-methyladenine;
Prostatic neoplasms;
Review
- From:
International Journal of Surgery
2021;48(12):852-857
- CountryChina
- Language:Chinese
-
Abstract:
Prostate cancer is one of the leading cause of male cancer-related death worldwide, and the treatment of high-risk prostate cancer and castration resistant prostate cancer remains a significant challenge. Epigenetic modification has been paid more attention in the field of tumor, as a common RNA modification in eukaryotic cells, N6-methyladenosine (m6A) methylation is a dynamic and reversible process regulated by m6A methyltransferase, demethylase and recognition protein, which can regulate the physiological process and tumor progression by regulating gene expression. m6A modification plays an important role in the occurrence and development of prostate cancer and is expected to become a new target in diagnosis, treatment and prognosis. This article reviews the m6A modification and its expression, function and mechanism in prostate cancer, as well as new ideas for clinical application.
